NCT07219433 Implementing a Mobile Health Application for Women Veterans With Urinary Incontinence (MyHealtheBladder): Function QUERI 3.0
| NCT ID | NCT07219433 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Urinary Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-04-30 |
| Primary Completion | 2030-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-04-30 with a primary completion date of 2030-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Implementing a Mobile Health Application for Women Veterans with Urinary Incontinence (MyHealtheBladder): Function QUERI 3.0 aims to compare implementation approaches while also gathering information on clinical effects of the Evidence-Based Program (EBP) in its new context and focusing on equitable reach (extent to which the program serves all members of its intended audience). The overall goal is to implement, evaluate, and sustain MyHealtheBladder in 20 VA facilities using a type III effectiveness-implementation hybrid study framework and parallel cluster randomized trial (CRT) design.
Eligibility Criteria
Inclusion Criteria: Site Inclusion Criteria: * Facility is part of the U.S. Department of Veterans Affairs (VA) health system. * Clinic serves at least 100 Women Veterans annually. * Identified site champion (e.g., clinician or staff member) who is willing to assume required program responsibilities for implementation. Patient Inclusion Criteria: * Women Veterans * Have any type of Urinary Incontinence existing for at least 3 months Exclusion Criteria: Site Exclusion Criteria: * Clinic has already implemented the MyHealtheBladder program. Patient Exclusion Criteria: * No access to computer or mobile device * No email account * Institutionalized
Contact & Investigator
Karen Goldstein, MD MSPH
PRINCIPAL INVESTIGATOR
Durham VA Medical Center, Durham, NC
Frequently Asked Questions
Who can join the NCT07219433 clinical trial?
This trial is open to female participants only, studying Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07219433 currently recruiting?
Yes, NCT07219433 is actively recruiting participants. Contact the research team at Caitlin.Kappler@va.gov for enrollment information.
Where is the NCT07219433 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT07219433 clinical trial?
NCT07219433 is sponsored by VA Office of Research and Development. The principal investigator is Karen Goldstein, MD MSPH at Durham VA Medical Center, Durham, NC. The trial plans to enroll 20 participants.